07:51

ADMINISTER trial: Digital consults to optimize GDMT in HF part 2

10:32

ESC 2024 Highlights

06:51

Digital optimization of GDMT for HF

09:52

DanGer Shock: Microaxial Flow Pump versus Standard Care in Infarct-Related Cardiogenic Shock

13:44

EuroPCR 2024 Highlights

04:18

Intravascular imaging-guided PCI and standardized optimized protocols

03:03

Long term mortality of target lesion revascularization for left main disease

16:01

RELIEVE-HF: Interatrial shunt in patients with heart failure

11:06

ACC 24 Highlights

03:48

Pharmacoinvasive approach for cardiogenic shock with prolonged transport times

02:49

ISCHEMIA trial: Revascularization strategies in stable CAD

03:03

Valvular and perivalvular thrombus after TAVR: Risks and Outcomes

03:56

PROTECT III: Role of LVEF in high-risk PCI with pLVAD

01:25

TAVI vs SAVR: 10 year outcomes

03:23

Long-term risk of stroke after TAVR

06:18

Incidence, outcomes and predictors of bleeding after transfemoral TAVR

04:54

Global trends in cardiovascular disease

01:24

Resynchronization-defibrillation for heart failure

06:15

Mechanisms of ischemia in patients with myocardial bridges

12:19

AHA 2023 Highlights

07:29

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

01:19

ORBITA 2: The power of PCI revealed for stable angina

14:41

TCT 2023 Highlights

03:51

OCT vs angiography

18:00

Cardiac resynchronisation in heart failure with right ventricular pacing

09:48

Exploring Qiliqiangxin's Impact on Heart Failure

06:01

HEART-FID trial: Intravenous ferric carboxymaltose for heart failure with iron deficiency

11:10

OCT vs IVUS vs angiography meta-analysis

04:45

Colchicine for prevention of atrial fibrillation after major thoracic surgery

06:05

Semaglutide's Impact on Obesity-Related Heart Failure with Preserved Ejection Fraction

05:45

Oral anticoagulation in patients with atrial high rate episodes

15:27

ESC Congress 2023 Highlights

12:45

Beta-blockers in stable ischemic heart disease

09:58

Pre-Hospital rule-out of ACS leads to less costs and MACE

01:20

Comparing CABG and PCI Outcomes in Left Main Coronary Artery Disease: Observational Study Findings

15:57

EuroPCR 2023 Highlights with Dr. Chadi Alraies

04:24

Inflammation as predictor of future CV event risk

01:32

TRILUMINATE: Transcatheter repair of tricuspid regurgitation

19:59

ACC 2023 Highlights with Chadi Alraies

05:10

Acute coronary occlusion in non-STEMI out-of-hospital cardiac arrest

01:28

FRAME AMI: FFR vs angiography-guided PCI in acute MI multivessel disease

09:37

Environmental impact of cardiac catheterizations

09:31

PROGRESS CTO: Predicting coronary artery perforation during PCI

01:21

REVIVED BCIS2 trial

01:21

FAME 3 trial: FFR-guided PCI vs CABG

01:17

COAPT Trial - Renal dysfunction and cardiac outcomes in heart failure

01:33

EMPEROR Preserved: Empagliflozin in heart failure with preserved ejection fraction

02:37

Value of real-world DOAC data on AF treatment

01:37

Empagliflozin and heart failure

01:16

COVID19 & Cardiac arrest

01:25

SGLT2i and GLP 1RA Cardiac outcomes

02:58

ARTICA Trial

01:33

Statins vs placebo - N of 1 trial

01:18

Thromboembolism in COVID19 patients

01:15

EXCEL trial : Repeat revascularization after PCI vs CABG

03:02

iMODERN: When to treat non-culprit lesions

02:53

Immediate vs Delayed Coronary Angiography

02:14

COVID19 and the heart

01:26

COVID-19 What you need to know

01:59

Transradial access complications video